High-dose bone morphogenetic protein-induced ectopic abdomen bone growth

Spine Journal

Volumn 10, Issue 2, 2010, Pages

  Deutsch, Harel ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone morphogenetic protein; Ectopic bone growth; Lumbar fusion

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ABDOMINAL SURGERY; ADULT; ARTICLE; BONE DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECTOPIC BONE GROWTH; HUMAN; INTERVERTEBRAL DISK DEGENERATION; LOW BACK PAIN; MALE; OSTEOTOMY; PRIORITY JOURNAL; PSEUDARTHROSIS; SEROMA; SPINE FUSION; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; WEIGHT REDUCTION;

BONE MORPHOGENETIC PROTEIN 2; HUMANS; INTERVERTEBRAL DISK DEGENERATION; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; PSEUDARTHROSIS; RECOMBINANT PROTEINS; RETROPERITONEAL SPACE; SPINAL FUSION; THORACIC VERTEBRAE; TREATMENT OUTCOME;

EID: 75149162762     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2009.10.016     Document Type: Article

References (9)

1. Burkus J.K., Gornet M.F., Dickman C.A., and Zdeblick T.A. Anterior lumbar interbody fusion using rhBMP-2 with tapered inter body cages. J Spinal Disord Tech 15 (2002) 337-347
2. Vaidya R., Sethi A., Bartol S., et al. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech 21 (2008) 557-562
3. Benglis D., Wang M.Y., and Levi A.D. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 62 5 Suppl 2 (2008) 423-431
4. Wong D.A., Kumar A., Jatana S., et al. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 8 (2008) 1011-1018
5. Arrington E.D., Smith W.J., Chambers H.G., et al. Complications of iliac crest bone graft harvesting. Clin Orthop 329 (1996) 300-309
6. Federal Drug Administration. Summary of safety and effectiveness. InFUSE bone graft/LT-cage lumbar tapered fusion device. June 2002. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf/P000058b.pdf. Accessed February 19, 2009.
7. Shields L.B., Raque G.H., Glassman S.D., et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31 (2006) 542-547
8. Smucker J.D., Rhee J.M., Singh K., et al. Increase swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31 (2006) 2813-2819
9. Lewandrowski K.U., Nanson C., and Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of 5 cases. Spine J 7 (2007) 609-614